American Journal of Hematology
American Journal of Hematology is a monthly peer-reviewed journal published by John Wiley and Sons, covering hematology. Founded in 1976, it is a leading journal in hematology, with a 2025 impact factor of 9.4, indexed in SCIE.《美国血液学杂志》（American Journal of Hematology, 简称 AJH）是由约翰威立出版的月刊同行评审期刊，涵盖血液学。该刊创刊于 1976 年，是血液学领域的领军期刊，2025 年影响因子为 9.4，被 SCIE 收录。
Scope
The journal's stated aim is to publish high-quality research and reviews in hematology that advance the understanding and treatment of blood disorders, with its official scope covering:刊物官方宗旨为发表推进血液疾病理解与治疗的高质量血液学研究与综述，官方声明的征稿范围包括：
- Malignant hematology: original research on leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and other hematologic malignancies, including diagnosis, prognosis, and therapy.恶性血液病： 关于白血病、淋巴瘤、多发性骨髓瘤、骨髓增生异常综合征及其他血液系统恶性肿瘤的原创研究，包括诊断、预后与治疗。
- Benign hematology: studies on anemia, bleeding and thrombotic disorders, hemoglobinopathies, and other non-malignant blood disorders.良性血液病： 关于贫血、出血与血栓性疾病、血红蛋白病及其他非恶性血液疾病的研究。
- Hematopoietic stem cells and transplantation: research on hematopoietic stem cell biology, stem cell transplantation, cell therapy, and regenerative medicine in hematology.造血干细胞与移植： 关于造血干细胞生物学、干细胞移植、细胞治疗以及血液学中再生医学的研究。
- Translational and clinical research: translational studies connecting basic hematology research to clinical practice, including clinical trials and novel therapeutic approaches.转化与临床研究： 连接基础血液学研究与临床实践的转化研究，包括临床试验与新型治疗方法。
- Article types: the journal publishes original research articles, review articles, brief reports, case reports, and correspondence.栏目设置： 该刊发表原创研究论文、综述、简报、病例报告与通讯。
History
- Founding: the journal was established in 1976, providing a dedicated forum for research in both malignant and benign hematology.创刊： 该刊于 1976 年创刊，为恶性与良性血液学研究提供专门论坛。
- Growth and impact: over the decades, the journal has grown to become one of the leading hematology journals, with a broad readership among hematologists and oncologists worldwide.成长与影响： 数十年来，该刊已发展为领先的血液学杂志之一，在全球血液学家与肿瘤学家中拥有广泛读者。
- Wiley publication: the journal is published by John Wiley and Sons, one of the largest academic publishers globally.Wiley 出版： 该刊由全球最大的学术出版商之一约翰威立出版。
- Monthly publication: the journal publishes twelve issues per year, with articles released online ahead of print on a continuous basis.月刊出版： 该刊每年出版 12 期，论文在线先于纸版持续发布。
Editors
The journal is led by an editor-in-chief supported by associate editors and an editorial board:该刊由主编领导，副主编与编委会协助工作：
- Editor-in-chief: Carlo Brugnara serves as the editor-in-chief, with expertise in hematology and laboratory medicine.主编： 卡洛·布鲁尼亚拉（Carlo Brugnara）担任主编，专长为血液学与检验医学。
- Associate editors: the editor-in-chief is supported by associate editors with expertise in major subfields of hematology.副主编： 主编由具有血液学主要分支领域专长的副主编协助。
- Editorial board: the journal has an international editorial board comprising hematologists and oncologists from leading institutions worldwide.编委会： 该刊拥有国际编委会，成员为来自全球顶尖机构的血液学家与肿瘤学家。
- Open access option: authors can choose to publish open access in this journal, making their articles freely available to readers upon publication in exchange for an article processing charge.开放获取选项： 作者可选择在该刊发表开放获取文章，使论文发表后即向读者免费开放，并支付文章处理费。